The Arterial Cannulae from Edwards is designed with the ability to go more places, help facilitate ease of insertion and promote optimal protection and performance. Specifically designed to help you ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...

The global arterial cannula market is anticipated to grow at a CAGR of around 7% during the forecast period. Growth in the market is driven by the rising prevalence of cardiovascular and chronic ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia ...

The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, ...

Terumo Cardiovascular Systems (Terumo CVS) has issued an urgent, nationwide/worldwide recall of its Tenderflow™ Pediatric Arterial Cannulae involving 21 lot codes. Terumo received five reports of ...

Genetic variants as predictive markers for ototoxicity and nephrotoxicity in patients (pts) with locally advanced head and neck cancer (LAHNC) treated with cisplatin-containing chemoradiotherapy ...

A 49 year old male with severely reduced systolic function, day six post two vessel coronary artery bypass (CABG) had cardiac arrest after which two sternotomy explorations were performed. The patient ...

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...